Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer
Stopped Funding was terminated
Conditions
- Neoplasms
- Head and Neck Neoplasms
Interventions
- DRUG: Oxaliplatin and Docetaxel
Sponsor
Minneapolis Veterans Affairs Medical Center
Collaborators